Skip to main content

Table 4 Liver transplantation and (case-concomitant) transplant evaluation & performed ELS therapy

From: Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015

  2007 2008 2009 2010 2011 2012 2013 2014 2015 2007–2015
Liver transplantations, n (%) 49 (15.6) 38 (12.2) 55 (14.1) 71 (18.8) 49 (17.1) 30 (11.1) 32 (12.5) 18 (6.1) 18 (4.6) 360 (12.4)
In-hospital Mortality 19 (38.8) 22 (57.9) 17 (30.9) 23 (32.4) 15 (30.6) 8 (26.7) 20 (62.5) 4 (22.2) 7 (38.9) 135 (37.5)
Evaluation & waiting list, n (%) 13 (4.14) 8 (2.57) 24 (6.15) 28 (7.43) 26 (9.06) 19 (7.04) 9 (3.53) 9 (3.06) 7 (1.80) 143 (4.95)
Evaluation & no waiting list, n (%) 0 6 (1.92) 2 (0.51) 5 (1.33) 1 (0.35) 3 (1.11) 1 (0.39) 4 (1.36) 3 (0.77) 25 (0.87)
Re-Evaluation, n (%) 3 (0.96) 1 (0.32) 6 (1.54) 2 (0.53) 3 (1.05) 0 3 (1.18) 1 (0.34) 0 19 (0.66)
  1. Data given as absolute numbers and percentage values of all ELS cases of the respective year. Documentation of transplant evaluations might underlie a relevant underreporting bias as numbers of performed liver transplantations are higher than documented evaluations for transplantation. The data source does not allow for differentiation if ELS therapy was used before or after liver transplantation due to national data protection laws. For details see text & Table 1